20,869
edits
Changes
Jump to navigation
Jump to search
→Apligraph Oral: Update URL.
== Apligraph Oral ==
Organogenesis is presently seeking [[FDA]] approval for Apligraph Oral, a [[foreskin]]-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFweb
|last=
|first=
|date=2011-11-17
|title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
|url=httphttps://www.fda.gov/downloadsadvisory-committees/AdvisoryCommitteesadvisory-committee-calendar/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdfcellular-tissue-and-gene-therapies-advisory-committee-september-2-3-2021-meeting-announcement
|publisher=
|accessdate=20112021-1209-2002
}}</ref>
[[Category:Company]]
[[Category:Financial gain]]
[[Category:Foreskin product]]
[[Category:From CircLeaks]]